Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Return on Equity (2020 - 2025)

Treace Medical Concepts' Return on Equity history spans 6 years, with the latest figure at 0.64% for Q4 2025.

  • For Q4 2025, Return on Equity fell 13.0% year-over-year to 0.64%; the TTM value through Dec 2025 reached 0.64%, down 13.0%, while the annual FY2025 figure was 0.57%, 12.0% down from the prior year.
  • Return on Equity reached 0.64% in Q4 2025 per TMCI's latest filing, down from 0.54% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.11% in Q3 2021 to a low of 97.72% in Q1 2021.
  • Average Return on Equity over 5 years is 5.29%, with a median of 0.46% recorded in 2022.
  • Peak YoY movement for Return on Equity: tumbled -460bps in 2021, then surged 9742bps in 2022.
  • A 5-year view of Return on Equity shows it stood at 0.22% in 2021, then tumbled by -186bps to 0.62% in 2022, then skyrocketed by 41bps to 0.36% in 2023, then tumbled by -42bps to 0.51% in 2024, then fell by -25bps to 0.64% in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Return on Equity are 0.64% (Q4 2025), 0.54% (Q3 2025), and 0.49% (Q2 2025).